SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : son of T/FIF

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: smh who wrote (417)1/10/2000 10:31:00 PM
From: John Metcalf   of 673
 
re: Smartmoney story

Only 14 profitable companies in the industry, and one of them is Gliatech, with less than $200mm in market cap. Since I live in the country in a redneck area, you might understand what I mean in that context: GLIA is one of few visible deer not hanging upside down in a tree. Gonna go after that sucker-:)

More seriously, where is the Moore's law company that will make biotech products affordable and universally used? Is it a humanizing MaB company, like ABGX, or MEDX, or PDLI? Is it a bio-chip maker like AFFX? Is it a metabolite/enantiomer/chiral switch company like Sepracor or Celgene or Celltech-Chiro? Is it a company that packages the Human Genome Project (INCY), or uses it (MLNM or CRA), or stakes out territory for itself (HGSI)? Is it a company with the bucks to buy any of the above (big pharmas and AMGN)? Is it a company that controls access to a specific market (say Taisho, Kirin, or Takeda) or can solve regulatory hurdles (Novartis, Glaxo, Roche)?

If a big new railroad is a-buildin', who mans the train, who owns the track, and who merely supplies the steel?

(On most days, I'd settle for just the steel, and have. But there's a larger vision here that I'd like to participate in.)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext